Literature DB >> 3281931

Alprazolam as an antidepressant.

M D Warner1, C A Peabody, H A Whiteford, L E Hollister.   

Abstract

Alprazolam appears to be an effective antidepressant in the treatment of outpatients who have a diagnosis of major depressive disorder. The authors have reviewed six controlled double-blind studies of alprazolam in the treatment of depression. Four of the six studies included only outpatients and clearly demonstrated a clinical effectiveness comparable to that of the tricyclics but with fewer, less severe side effects and better tolerance. The other two studies involved both inpatients and outpatients, so no conclusions can be drawn regarding the effectiveness of alprazolam in an inpatient population; further controlled studies are needed to answer this question. No satisfactory explanation exists for the mechanism of alprazolam's proposed antidepressant action.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3281931

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  9 in total

Review 1.  Dealing with sadness, madness and hostility. New psychotropic drug remedies for the future.

Authors:  A J Loonen
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

2.  Intractable depression in tertiary care.

Authors:  R H Gerner
Journal:  West J Med       Date:  1989-09

3.  Controlled comparison of two doses of milnacipran (F 2207) and amitriptyline in major depressive inpatients.

Authors:  M Ansseau; R von Frenckell; C Mertens; J de Wilde; L Botte; J M Devoitille; J L Evrard; A De Nayer; P Darimont; G Dejaiffe
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Intravenous alprazolam challenge in normal subjects. Biochemical, cardiovascular, and behavioral effects.

Authors:  E D Risby; J K Hsiao; R N Golden; W Z Potter
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Dose-dependent effects of intravenous alprazolam on neuroendocrine, biochemical, cardiovascular, and behavioral parameters in humans.

Authors:  O T Osman; J K Hsiao; W Z Potter
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Oral alprazolam acutely increases nucleus accumbens perfusion.

Authors:  D H Wolf; A E Pinkham; T D Satterthwaite; K Ruparel; M A Elliott; J Valdez; M A Smith; J A Detre; R C Gur; R E Gur
Journal:  Mol Psychiatry       Date:  2012-10-16       Impact factor: 15.992

Review 7.  Depression and its treatment in cardiac patients.

Authors:  F Fernandez
Journal:  Tex Heart Inst J       Date:  1993

Review 8.  Drug-induced depression. Incidence, avoidance and management.

Authors:  S B Patten; E J Love
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

Review 9.  Management of the psychological comorbidities of dermatological conditions: practitioners' guidelines.

Authors:  Cody J Connor
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-04-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.